Bharat Biotech gets nod to conduct phase-3, booster trial of intranasal vaccine
New Delhi: The subject expert committee (SEC) of Drugs controller General (India) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on its intranasal vaccine. The company had …
Bharat Biotech gets nod to conduct phase-3, booster trial of intranasal vaccine Read More